Edition:
United States

Affimed NV (AFMD.OQ)

AFMD.OQ on NASDAQ Stock Exchange Global Market

2.47USD
23 May 2018
Change (% chg)

$0.03 (+1.02%)
Prev Close
$2.45
Open
$2.45
Day's High
$2.47
Day's Low
$2.45
Volume
8,636
Avg. Vol
91,706
52-wk High
$2.85
52-wk Low
$1.17

Latest Key Developments (Source: Significant Developments)

Affimed Appoints Dr. Leila Alland As Chief Medical Officer
Monday, 19 Mar 2018 06:00am EDT 

March 19 (Reuters) - Affimed Nv ::AFFIMED APPOINTS DR. LEILA ALLAND AS CHIEF MEDICAL OFFICER.AFFIMED NV - ‍APPOINTMENT OF LEILA ALLAND TO POSITION OF CHIEF MEDICAL OFFICER (CMO), EFFECTIVE MARCH 26​.  Full Article

Affimed reports Q3 loss per share EUR 0.18
Tuesday, 7 Nov 2017 07:30am EST 

Nov 7 (Reuters) - Affimed Nv :Affimed reports financial results for third quarter 2017.Q3 loss per share EUR 0.18.Q3 earnings per share view EUR -0.17 -- Thomson Reuters I/B/E/S.Q3 revenue eur 500,000 versus EUR 900,000.Q3 revenue view EUR 933,000 -- Thomson Reuters I/B/E/S.  Full Article

Affimed announces Q3 financial results and corporate update conference call
Monday, 30 Oct 2017 06:01am EDT 

Oct 30 (Reuters) - Affimed Nv :Affimed announces third quarter 2017 financial results and corporate update conference call.  Full Article

Affimed Q2 loss per share EUR 0.24
Wednesday, 10 Aug 2016 07:30am EDT 

Affimed Nv : Affimed reports financial results for second quarter 2016 and provides corporate update . Q2 earnings per share view eur -0.20 -- Thomson Reuters I/B/E/S . Q2 loss per share eur 0.24 .Q2 revenue eur 2.1 million versus i/b/e/s view eur 1.9 million.  Full Article

BRIEF-Affimed Announces Proposed Public Offering Of Common Stock

* AFFIMED ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK Source text for Eikon: Further company coverage: